ADAR1 Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
34,314
+28,890
| +533% | +$1.36M | 0.25% | 60 |
|
|
2025
Q1 | $212K | Sell |
5,424
-12,000
| -69% | -$469K | 0.04% | 140 |
|
|
2024
Q4 | $944K | Sell |
17,424
-6,033
| -26% | -$327K | 0.19% | 78 |
|
|
2024
Q3 | $1.18M | Buy |
23,457
+18,657
| +389% | +$941K | 0.19% | 56 |
|
|
2024
Q2 | $211K | Buy |
4,800
+1,800
| +60% | +$79.1K | 0.04% | 133 |
|
|
2024
Q1 | $151K | Buy |
+3,000
| New | +$151K | 0.03% | 120 |
|